Osler is a leader in Canadian business law with a singular focus – your business. With an integrated network of offices in Toronto, Montréal, Calgary, Ottawa, Vancouver and New York, we have an undisputed reputation for solving problems, removing obstacles, and providing the answers you need, when you need them.

It’s an exciting time for both traditional players as well as start-ups and investors in the life sciences ecosystem with major scientific and technological advances propelling the industry forward. As the world adapts to new ways of delivering, receiving and monitoring health care with telemedicine, consumer wearable devices and the collection of related data, there are so many opportunities for inventors and investors.

At Osler, our lawyers work with private and public companies, from start-ups to industry leaders. We have modelled our practice to address client needs at every stage. Our top ranked Intellectual Property team is respected for its diverse strengths including excellence in IP litigation and in particular, our leading patent litigation practice, and for securing intellectual property rights through prosecution, licensing, and strategic portfolio advice. Osler acts as an essential business partner by developing and executing global intellectual property strategies in prosecution and litigation that align with our clients’ objectives. We have a massive presence in pharmaceutical-related litigation and dispute resolution, regarding patent, class action and other matters. Local and international clients from a broad range of industries retain Osler for our leading IP prosecution services, before every level of the Canadian courts as well as before international tribunals.

The firm routinely acts as counsel to the world’s largest and leading generic pharmaceutical companies. Strategically situated in the major English and French-speaking R&D hubs of Toronto, Montréal, Vancouver and Ottawa, we help guide investors, emerging and established companies and research organizations manage through all stages of growth.
We also represent many clients on the buy-side in this sector, including private equity groups, venture capital funds, angel investors and investment banks focused on this area of business. In addition to working with Canadian funds, we also advise various U.S. funds on their Canadian investing and in connection with exit transactions.

Our lawyers also bring expertise in corporate law, mergers and acquisitions, private and public financing transactions, fund formation, collaborations, technology transfer, licensing and regulatory matters. The members of our life sciences group hold relevant degrees in experimental medicine, biochemistry, pharmacy, veterinary medicine, pharmacology and epidemiology.

We take a multi-disciplinary approach, delivering more than just the core legal and litigation services. With deep industry and scientific expertise, our team integrates intellectual property, regulatory and commercial expertise into its services, enabling our life sciences clients to make the right business decisions in a fiercely competitive marketplace. If litigation for business-critical products becomes necessary, our litigation and intellectual property teams are battle-tested and at the ready.